{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:32:38Z","timestamp":1777415558794,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41433-024-03544-w","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:00:22Z","timestamp":1734631222000},"page":"449-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Current insights and challenges in the management of perifoveal vascular anomalous complex (PVAC): a systematic review of multimodal imaging features and treatment strategies"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-3506","authenticated-orcid":false,"given":"Paolo","family":"Forte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2999-6782","authenticated-orcid":false,"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-0532","authenticated-orcid":false,"given":"Mario R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"3544_CR1","doi-asserted-by":"publisher","first-page":"559.e1","DOI":"10.1016\/j.jfo.2011.03.002","volume":"34","author":"G Querques","year":"2011","unstructured":"Querques G, Kuhn D, Massamba N, Leveziel N, Querques L, Souied EH. Perifoveal exudative vascular anomalous complex. J Fr Ophtalmol. 2011;34:559.e1\u2013e4.","journal-title":"J Fr Ophtalmol"},{"key":"3544_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2017.10.009","volume":"184","author":"R Sacconi","year":"2017","unstructured":"Sacconi R, Freund KB, Yannuzzi LA, Dolz-Marco R, Souied E, Capuano V, et al. The expanded spectrum of perifoveal exudative vascular anomalous complex. Am J Ophthalmol. 2017;184:137\u201346.","journal-title":"Am J Ophthalmol"},{"key":"3544_CR3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3928\/23258160-20181203-11","volume":"49","author":"AG Ayachit","year":"2018","unstructured":"Ayachit AG, Sacconi R, Ayachit GS, Joshi S, Querques G. Perifoveal exudative vascular anomalous complexlike lesion as a complication of prepapillary arterial loops. Ophthalmic Surg Lasers Imaging Retin. 2018;49:974\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"3544_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/OPX.0000000000001401","volume":"96","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Xu L, Wu Z, Zhang J. Case report: perifoveal exudative vascular anomalous complex in a Chinese patient with diabetes mellitus. Optom Vis Sci. 2019;96:531\u20135.","journal-title":"Optom Vis Sci"},{"key":"3544_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cxo.12868","volume":"102","author":"R Venkatesh","year":"2019","unstructured":"Venkatesh R, Yadav NK, Bavaharan B, Prabhu V, Sinha S. Multimodal imaging in perifoveal exudative vascular anomalous complex with co-existent diabetic retinopathy. Clin Exp Optom. 2019;102:528\u201332.","journal-title":"Clin Exp Optom"},{"key":"3544_CR6","doi-asserted-by":"crossref","unstructured":"Damasceno N, Horowitz S, Yannuzzi NA, Flynn H Jr, Farah M, Damasceno E. Perifoveal exudative vascular anomalous complex and resembling lesions treated with intravitreal triamcinolone. Eur J Ophthalmol. 2024;34:NP84-NP89.","DOI":"10.1177\/11206721231178995"},{"key":"3544_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/ijo.IJO_1000_21","volume":"2","author":"A Nataraj","year":"2022","unstructured":"Nataraj A, Sheth J, Soman M, Nair U. Refractory perifoveal exudative vascular anomalous complex like lesion responding to intravitreal dexamethasone implant: a therapeutic challenge. Indian J Ophthalmol Case Rep. 2022;2:449.","journal-title":"Indian J Ophthalmol Case Rep"},{"key":"3544_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ajoc.2019.03.008","volume":"14","author":"J Siedlecki","year":"2019","unstructured":"Siedlecki J, Vounotrypidis E, Vogt D, Wolf A, Priglinger SG, Schumann RG. Lamellar hole-associated epiretinal proliferation presenting with perifoveal exudative vascular anomalous complex. Am J Ophthalmol Case Rep. 2019;14:112\u20136.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3544_CR9","doi-asserted-by":"crossref","unstructured":"Mrejen S, Le HM, Nghiem-Buffet S, Tabary S, Quentel G, Cohen SY. Insights into perifoveal exudative vascular anomalous complex. Retina. 2020;40:80\u20136.","DOI":"10.1097\/IAE.0000000000002435"},{"key":"3544_CR10","doi-asserted-by":"crossref","unstructured":"Herda N, Semoun O, Srour M, Amoroso F, Baker M, Capuano V, et al. Atypical case of perifoveal exudative vascular anomalous complex associated with pachychoroid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2022;28:101691.","DOI":"10.1016\/j.ajoc.2022.101691"},{"key":"3544_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/08820538.2019.1626450","volume":"34","author":"JH Kim","year":"2019","unstructured":"Kim JH, Kim JW, Kim CG, Lee DW. Characteristics of perifoveal exudative vascular anomalous complex in Korean patients. Semin Ophthalmol. 2019;34:353\u20138.","journal-title":"Semin Ophthalmol"},{"key":"3544_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3928\/23258160-20221219-01","volume":"54","author":"C Arruabarrena","year":"2023","unstructured":"Arruabarrena C, Lia\u00f1o G, Hern\u00e1ez-Leonato JM, Mart\u00ednez-S\u00e1nchez M, Ca\u00f1as-Mart\u00edn J, Teus MA. Selective focal laser therapy as the primary treatment for exudative perifoveal vascular anomalous complex (ePVAC): case series and literature review. Ophthalmic Surg Lasers Imaging Retin Slack Incorporated. 2023;54:43\u20139.","journal-title":"Ophthalmic Surg Lasers Imaging Retin Slack Incorporated"},{"key":"3544_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajo.2020.04.025","volume":"218","author":"R Sacconi","year":"2020","unstructured":"Sacconi R, Borrelli E, Sadda SV, Corradetti G, Freund KB, Yannuzzi LA, et al. Nonexudative perifoveal vascular anomalous complex: the subclinical stage of perifoveal exudative vascular anomalous complex? Am J Ophthalmol. 2020;218:59\u201367.","journal-title":"Am J Ophthalmol"},{"key":"3544_CR14","first-page":"1219","volume":"43","author":"I Zucchiatti","year":"2023","unstructured":"Zucchiatti I, Sacconi R, Saladino A, Bandello F, Querques G. Perifoveal vascular anomalous complex and the spectrum of degenerative microvascular macular diseases. Retina. 2023;43:1219\u201325.","journal-title":"Retina"},{"key":"3544_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/ijo.IJO_1706_20","volume":"1","author":"S Reddy","year":"2021","unstructured":"Reddy S, Agrawal H, Agarwal K. Focal laser photocoagulation in the management of perifoveal exudative vascular anomalous complex. Indian J Ophthalmol Case Rep. 2021;1:323.","journal-title":"Indian J Ophthalmol Case Rep"},{"key":"3544_CR16","doi-asserted-by":"publisher","first-page":"NP119","DOI":"10.1177\/1120672120966564","volume":"32","author":"J Henriques","year":"2022","unstructured":"Henriques J, Pinto F, Rosa PC, Medeiros MD, Reis Cabral D, Henriques S, et al. Continuous wave milipulse yellow laser treatment for perifoveal exudative vascular anomalous complex-like lesion: a case report. Eur J Ophthalmol. 2022;32:NP119\u201324.","journal-title":"Eur J Ophthalmol"},{"key":"3544_CR17","doi-asserted-by":"publisher","first-page":"NP87","DOI":"10.1177\/11206721221149064","volume":"33","author":"P Sagar","year":"2023","unstructured":"Sagar P, Sahare H, Shanmugam PM, Biswal S, Ravishankar HN. Laser photocoagulation of a hypofluorescent perifoveal exudative vascular anomalous complex\/capillary macroaneurysm. Eur J Ophthalmol. 2023;33:NP87\u201391.","journal-title":"Eur J Ophthalmol"},{"key":"3544_CR18","doi-asserted-by":"crossref","unstructured":"Corvi F, Corradetti G, Juhn A, Sadda S. Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation. Am J Ophthalmol Case Rep. 2020;20:100883.","DOI":"10.1016\/j.ajoc.2020.100883"},{"key":"3544_CR19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jfo.2021.03.011","volume":"45","author":"L Remol\u00ed-Sargues","year":"2022","unstructured":"Remol\u00ed-Sargues L, Montero-Hern\u00e1ndez J, Monferrer Adsuara C, Castro Navarro V, Cervera-Taulet E. Perifoveal exudative vascular anomalous complex treated with navigated retina laser. J Fr Ophtalmol. 2022;45:e9\u201311.","journal-title":"J Fr Ophtalmol"},{"key":"3544_CR20","doi-asserted-by":"publisher","first-page":"757313","DOI":"10.3389\/fmed.2021.757313","volume":"8","author":"M Fu","year":"2021","unstructured":"Fu M, Hu P, Zhang G, Huang L, Xu H, Huang J, et al. Case report: a case of perifoveal exudative vascular anomalous complex with a good prognosis. Front Med. 2021;8:757313.","journal-title":"Front Med"},{"key":"3544_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/ICB.0000000000001181","volume":"17","author":"YK Kang","year":"2023","unstructured":"Kang YK, Park HS. Multiple-session subthreshold micropulse laser therapy for exudative perifoveal vascular anomalous complex: a case report. Retin Cases Brief Rep. 2023;17:324\u20138.","journal-title":"Retin Cases Brief Rep"},{"key":"3544_CR22","doi-asserted-by":"publisher","first-page":"101472","DOI":"10.1016\/j.ajoc.2022.101472","volume":"26","author":"B Tombolini","year":"2022","unstructured":"Tombolini B, Cavalleri M, Sacconi R, Querques L, Zucchiatti I, Bandello F, et al. Progressive resolution of exudation from perifoveal vascular anomalous complex: a possible role of diclofenac therapy? Am J Ophthalmol Case Rep. 2022;26:101472.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3544_CR23","doi-asserted-by":"crossref","unstructured":"Zhang K, Rachitskaya A. A review of perifoveal exudative vascular anomalous complex. Curr Ophthalmol Rep. 2022;10:162\u20137.","DOI":"10.1007\/s40135-022-00293-5"},{"key":"3544_CR24","unstructured":"Saxena S, Spaide RF, Souied EH, Lai TYY. Kim Editor IK Macular Disorders [Internet]. Available from: http:\/\/www.springer.com\/series\/16451."},{"key":"3544_CR25","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1097\/IAE.0000000000002406","volume":"39","author":"RF Spaide","year":"2019","unstructured":"Spaide RF, Barquet LA. Retinal capillary macroaneurysms. Retina. 2019;39:1889\u201395.","journal-title":"Retina"},{"key":"3544_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/aos.14650","volume":"99","author":"LM Smid","year":"2021","unstructured":"Smid LM, Verhoekx JSN, Martinez Ciriano JP, Vermeer KA, Yzer S. Multimodal imaging comparison of perifoveal exudative vascular anomalous complex and resembling lesions. Acta Ophthalmol. 2021;99:553\u20138.","journal-title":"Acta Ophthalmol"},{"key":"3544_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.oftal.2023.04.010","volume":"98","author":"M Sotomayor-Toribio","year":"2023","unstructured":"Sotomayor-Toribio M, L\u00f3pez-Herrero F, S\u00e1nchez-Vicente JL, Gonz\u00e1lez-J\u00e1uregui B, Rodr\u00edguez-Fern\u00e1ndez C, Su\u00e1rez-P\u00e9rez J. Perifoveal exudative vascular anomalous complex (PEVAC). Arch Soc Esp Oftalmol. 2023;98:417\u201321.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"3544_CR28","doi-asserted-by":"crossref","unstructured":"Jadnanansing AI, Martinez Ciriano JP, van Droogenbroeck J, Spielberg L, Vanhonsebrouck E. Perifoveal exudative vascular anomalous complex (PEVAC) resembling lesion in a patient with multiple myeloma. Am J Ophthalmol Case Rep. 2023;34:101891.","DOI":"10.1016\/j.ajoc.2023.101891"},{"key":"3544_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3928\/23258160-20191119-08","volume":"50","author":"HK Banda","year":"2019","unstructured":"Banda HK, Dang S, Rothman RJ. Perifoveal exudative vascular anomalous complex with suspended scattered particles in motion. Ophthalmic Surg Lasers Imaging Retin. 2019;50:796\u2013800.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"3544_CR30","doi-asserted-by":"crossref","unstructured":"Temkar S, Natarajan K, Deb AK, Sagar P. Exudative vascular anomalous complex-like lesion of the peripapillary area. Eur J Ophthalmol. 2024;34:NP83-NP86.","DOI":"10.1177\/11206721231202895"},{"key":"3544_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jfo.2023.02.010","volume":"46","author":"A Simon","year":"2023","unstructured":"Simon A, Mercier AE, Chan G, Williamson W. Multimodal imaging of perifoveal exudative vascular anomalous complex (PEVAC). J Fr Ophtalmol. 2023;46:968\u201371.","journal-title":"J Fr Ophtalmol"},{"key":"3544_CR32","doi-asserted-by":"crossref","unstructured":"Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. 2006. Retina. 2012;32 Suppl 1:450\u201360.","DOI":"10.1097\/IAE.0b013e31823f9a59"},{"key":"3544_CR33","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ophtha.2004.12.038","volume":"112","author":"LM Smithen","year":"2005","unstructured":"Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF. Coats\u2019 disease diagnosed in adulthood. Ophthalmology. 2005;112:1072\u20138.","journal-title":"Ophthalmology"},{"key":"3544_CR34","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","volume":"36","author":"D Su","year":"2016","unstructured":"Su D, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, et al. An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography. Retina. 2016;36:S40\u20139.","journal-title":"Retina"},{"key":"3544_CR35","doi-asserted-by":"crossref","unstructured":"Ueda T, Gomi F, Suzuki M, Sakaguchi H, Sawa M, Kamei M, et al. Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment. Retina. 2012;32:308\u201313.","DOI":"10.1097\/IAE.0b013e31821c40a9"},{"key":"3544_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/bjophthalmol-2019-314355","volume":"104","author":"D Castro Far\u00edas","year":"2020","unstructured":"Castro Far\u00edas D, Matsui Serrano R, Bianchi Gancharov J, De Dios Cuadras U, Sahel J, Graue Wiechers F, et al. Indocyanine green angiography for identifying telangiectatic capillaries in diabetic macular oedema. Br J Ophthalmol. 2020;104:509\u201313.","journal-title":"Br J Ophthalmol"},{"key":"3544_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archopht.1982.01030030773010","volume":"100","author":"JD Gass","year":"1982","unstructured":"Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100:769\u201380.","journal-title":"Arch Ophthalmol"},{"key":"3544_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2016.04.005","volume":"167","author":"A Matet","year":"2016","unstructured":"Matet A, Daruich A, Dirani A, Ambresin A, Behar-Cohen F. Macular telangiectasia type 1: capillary density and microvascular abnormalities assessed by optical coherence tomography angiography. Am J Ophthalmol. 2016;167:18\u201330.","journal-title":"Am J Ophthalmol"},{"key":"3544_CR39","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1097\/IAE.0000000000001424","volume":"37","author":"L Kowalczuk","year":"2017","unstructured":"Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, et al. Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile. Retina. 2017;37:2226\u201337.","journal-title":"Retina"},{"key":"3544_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00417-008-0795-6","volume":"246","author":"MA Gamulescu","year":"2008","unstructured":"Gamulescu MA, Walter A, Sachs H, Helbig H. Bevacizumab in the treatment of idiopathic macular telangiectasia. Graefe\u2019s Arch Clin Exp Ophthalmol. 2008;246:1189\u201393.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"3544_CR41","first-page":"1357","volume":"7","author":"A Rouvas","year":"2013","unstructured":"Rouvas A, Malamos P, Douvali M, Ntouraki A, Markomichelakis NN. Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia. Clin Ophthalmol. 2013;7:1357\u201362.","journal-title":"Clin Ophthalmol"},{"key":"3544_CR42","first-page":"1","volume":"2014","author":"O Shibeeb","year":"2014","unstructured":"Shibeeb O, Vaze A, Gillies M, Gray T. Macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab. Case Rep. Ophthalmol Med. 2014;2014:1\u20134.","journal-title":"Case Rep. Ophthalmol Med"},{"key":"3544_CR43","first-page":"1","volume":"2014","author":"M Loutfi","year":"2014","unstructured":"Loutfi M, Papathomas T, Kamal A. Macular oedema related to idiopathic macular telangiectasia type 1 treated with dexamethasone intravitreal implant (Ozurdex). Case Rep Ophthalmol Med. 2014;2014:1\u20135.","journal-title":"Case Rep Ophthalmol Med"},{"key":"3544_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000509850","volume":"12","author":"P Cirafici","year":"2021","unstructured":"Cirafici P, Musolino M, Saccheggiani M, Traverso CE, Nicol\u00f2 M. Multimodal imaging findings and treatment with dexamethasone implant in three cases of idiopathic macular telangiectasia type 1. Case Rep Ophthalmol. 2021;12:92\u20137.","journal-title":"Case Rep Ophthalmol"},{"key":"3544_CR45","doi-asserted-by":"crossref","unstructured":"Parodi MB, Da Pozzo S, Saviano S, Ravalico G. Branch retinal vein occlusion and macroaneurysms. Int Ophthalmol. 1997;21:161\u20134.","DOI":"10.1023\/A:1026420707368"},{"key":"3544_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/bjophthalmol-2015-308142","volume":"101","author":"M Paques","year":"2017","unstructured":"Paques M, Philippakis E, Bonnet C, Falah S, Ayello-Scheer S, Zwillinger S, et al. Indocyanine-green-guided targeted laser photocoagulation of capillary macroaneurysms in macular oedema: a pilot study. Br J Ophthalmol. 2017;101:170\u20134.","journal-title":"Br J Ophthalmol"},{"key":"3544_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/OPTH.S393360","volume":"17","author":"J Itou","year":"2023","unstructured":"Itou J, Furushima K, Haruta M, Kato N, Arai R, Mori K, et al. Reduced size of telangiectatic capillaries after intravitreal injection of anti-vascular endothelial growth factor agents in diabetic macular edema. Clin Ophthalmol. 2023;17:239\u201345.","journal-title":"Clin Ophthalmol"},{"key":"3544_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01183-9","volume":"11","author":"HC Roh","year":"2021","unstructured":"Roh HC, Lee C, Kang SW, Choi KJ, Eun JS, Hwang S. Infrared reflectance image-guided laser photocoagulation of telangiectatic capillaries in persistent diabetic macular edema. Sci Rep. 2021;11:21769.","journal-title":"Sci Rep"},{"key":"3544_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00417-009-1175-6","volume":"248","author":"A Bourhis","year":"2010","unstructured":"Bourhis A, Girmens JF, Boni S, Pecha F, Favard C, Sahel JA, et al. Imaging of macroaneurysms occurring during retinal vein occlusion and diabetic retinopathy by indocyanine green angiography and high resolution optical coherence tomography. Graefe\u2019s Arch Clin Exp Ophthalmol. 2010;248:161\u20136.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"3544_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/ICB.0000000000001378","volume":"18","author":"EL Perrin","year":"2024","unstructured":"Perrin EL, Porter RGB. Indocyanine green angiography\u2013guided photocoagulation of large microvascular abnormalities (\u201cTelcaps\u201d) in a patient with persistent macula edema in the context of radiation retinopathy. Retin Cases Brief Rep. 2024;18:355\u20139.","journal-title":"Retin Cases Brief Rep"},{"key":"3544_CR51","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1097\/IAE.0000000000003598","volume":"42","author":"R Sacconi","year":"2022","unstructured":"Sacconi R, Forte P, Capuano V, Miere A, Costanzo E, Tombolini B, et al. Optical coherence tomography angiography characterization of evolving lesions in fellow eyes of exudative type 3 macular neovascularization patients. Retina. 2022;42:2075\u201382.","journal-title":"Retina"},{"key":"3544_CR52","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/IAE.0000000000000835","volume":"35","author":"L Kuehlewein","year":"2015","unstructured":"Kuehlewein L, Dansingani KK, de Carlo TE, Bonini Filho MA, Iafe NA, Lenis TL, et al. Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration. Retina. 2015;35:2229\u201335.","journal-title":"Retina"},{"key":"3544_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bjophthalmol-2016-308815","volume":"101","author":"N Phasukkijwatana","year":"2017","unstructured":"Phasukkijwatana N, Tan ACS, Chen X, Freund KB, Sarraf D. Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy. Br J Ophthalmol. 2017;101:597\u2013602.","journal-title":"Br J Ophthalmol"},{"key":"3544_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","volume":"21","author":"LA YANNUZZI","year":"2001","unstructured":"Yannuzzi LA, Negr\u00e3o S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416\u201334.","journal-title":"Retina"},{"key":"3544_CR55","doi-asserted-by":"crossref","unstructured":"Forte P, Fontana V, Muzio J, Di Cello L, Corazza P, Rosa R, et al. Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation. Br J Ophthalmol. 2024;bjo-2023-324713.","DOI":"10.1136\/bjo-2023-324713"},{"key":"3544_CR56","doi-asserted-by":"crossref","unstructured":"Feo A, Stradiotto E, Sacconi R, Menean M, Querques G, Romano MR. Subretinal hyperreflective material in retinal and chorioretinal disorders: a comprehensive review. Surv Ophthalmol. 2024;69:362\u201377.","DOI":"10.1016\/j.survophthal.2023.10.013"},{"key":"3544_CR57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.oret.2022.02.010","volume":"6","author":"R Sacconi","year":"2022","unstructured":"Sacconi R, Forte P, Tombolini B, Grosso D, Fantaguzzi F, Pina A, et al. OCT predictors of 3-year visual outcome for type 3 macular neovascularization. Ophthalmol Retina. 2022;6:586\u201394.","journal-title":"Ophthalmol Retina"},{"key":"3544_CR58","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1097\/IAE.0000000000001564","volume":"37","author":"F Gilani","year":"2017","unstructured":"Gilani F, Gal-Or O, Freund KB. Spontaneous rupture and involution of a \u2018macro-microaneurysm\u2019 in diabetic retinopathy. Retina. 2017;37:e73\u20134.","journal-title":"Retina"},{"key":"3544_CR59","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1159\/000526991","volume":"13","author":"N Torrell-Belzach","year":"2022","unstructured":"Torrell-Belzach N, Miere A, Souied E, Cohen SY. Long-term resolution of perifoveal exudative vascular anomalous complex after intravitreal injections of anti-vascular endothelial growth factor. Case Rep. Ophthalmol. 2022;13:927\u201333.","journal-title":"Case Rep. Ophthalmol"},{"key":"3544_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100717","volume":"18","author":"JI Fern\u00e1ndez-Vigo","year":"2020","unstructured":"Fern\u00e1ndez-Vigo JI, Burgos-Blasco B, Dolz-Marco R, Jim\u00e9nez-Santos M, L\u00f3pez-Guajardo L, Donate-L\u00f3pez J. Atypical perifoveal exudative vascular anomalous complex (PEVAC) with multifocal and bilateral presentation. Am J Ophthalmol Case Rep. 2020;18:100717.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3544_CR61","doi-asserted-by":"crossref","unstructured":"Cunha de Souza E, Tombolini B, Sacconi R, Bandello F, Querques G. A Brazilian case of exudative perifoveal vascular anomalous complex responsive to aflibercept intravitreal injections. Eur J Ophthalmol. 2024;34:NP68-NP72.","DOI":"10.1177\/11206721231200116"},{"key":"3544_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/IAE.0000000000002809","volume":"41","author":"JSN Verhoekx","year":"2021","unstructured":"Verhoekx JSN, Smid LM, Vermeer KA, Martinez Ciriano JP, Yzer S. Anatomical changes on sequential multimodal imaging in perifoveal exudative vascular anomalous complex. Retina. 2021;41:162\u20139.","journal-title":"Retina"},{"key":"3544_CR63","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.3390\/jcm13195729","volume":"13","author":"T Sorrentino","year":"2024","unstructured":"Sorrentino T, Allegrini D, De Rosa G, Santoru F, Crepaldi L, Feo A, et al. Settings and clinical applications of subthreshold micropulse laser therapy: a review. J Clin Med. 2024;13:5729.","journal-title":"J Clin Med"},{"key":"3544_CR64","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2147\/OPTH.S79948","volume":"9","author":"PU Dugel","year":"2015","unstructured":"Dugel PU, Bandello F, Loewenstein A. Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol. 2015;9:1321\u201335.","journal-title":"Clin Ophthalmol"},{"key":"3544_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1568010053622975","volume":"4","author":"Y Monnier","year":"2005","unstructured":"Monnier Y, Zaric J, R\u00fcegg C. Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back. Curr Drug Targets Inflamm Allergy. 2005;4:31\u20138.","journal-title":"Curr Drug Targets Inflamm Allergy"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03544-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:00:04Z","timestamp":1738756804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03544-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3544"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03544-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}